ID17875A - PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID - Google Patents
PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACIDInfo
- Publication number
- ID17875A ID17875A IDP972848A ID972848A ID17875A ID 17875 A ID17875 A ID 17875A ID P972848 A IDP972848 A ID P972848A ID 972848 A ID972848 A ID 972848A ID 17875 A ID17875 A ID 17875A
- Authority
- ID
- Indonesia
- Prior art keywords
- oxsobutanoic
- acid
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9610254A FR2752422B1 (en) | 1996-08-16 | 1996-08-16 | PHARMACEUTICAL COMPOSITION CONTAINING 4-OXO-BUTANOIC ACIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID17875A true ID17875A (en) | 1998-02-05 |
Family
ID=9495089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP972848A ID17875A (en) | 1996-08-16 | 1997-08-14 | PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6143787A (en) |
| EP (1) | EP0925273B1 (en) |
| JP (1) | JP3105545B2 (en) |
| KR (1) | KR100488430B1 (en) |
| CN (1) | CN1082370C (en) |
| AR (1) | AR009251A1 (en) |
| AT (1) | ATE208364T1 (en) |
| AU (1) | AU725440B2 (en) |
| BR (1) | BR9711315A (en) |
| CA (1) | CA2263348C (en) |
| CY (1) | CY2298B1 (en) |
| CZ (1) | CZ294165B6 (en) |
| DE (1) | DE69708130T2 (en) |
| DK (1) | DK0925273T3 (en) |
| ES (1) | ES2166098T3 (en) |
| FR (1) | FR2752422B1 (en) |
| HU (1) | HUP0004223A3 (en) |
| ID (1) | ID17875A (en) |
| NO (1) | NO312290B1 (en) |
| PL (1) | PL187371B1 (en) |
| PT (1) | PT925273E (en) |
| RU (1) | RU2175966C2 (en) |
| SI (1) | SI0925273T1 (en) |
| SK (1) | SK283055B6 (en) |
| TR (1) | TR199900329T2 (en) |
| TW (1) | TW438764B (en) |
| UA (1) | UA57031C2 (en) |
| WO (1) | WO1998007681A1 (en) |
| ZA (1) | ZA977327B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04318852A (en) * | 1991-04-18 | 1992-11-10 | Fujitsu Ltd | Resist pattern forming method |
| MXPA03011558A (en) | 2001-06-12 | 2004-03-26 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS. |
| FR2832633B1 (en) * | 2001-11-28 | 2004-09-24 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING A METFORMIN ASSOCIATION AND A 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES |
| FR2832925B1 (en) | 2001-12-03 | 2006-07-14 | Lipha | USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF INFLAMMATION |
| FR2834214B1 (en) * | 2001-12-28 | 2004-09-24 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES |
| FR2834640B1 (en) * | 2002-01-11 | 2004-09-24 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING A GLITAZONE AND A 4-OXOBUTANOIC ACID AND ITS USE FOR TREATING DIABETES |
| CA2502297C (en) * | 2002-11-01 | 2011-12-13 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| ATE468114T1 (en) * | 2002-11-08 | 2010-06-15 | High Point Pharmaceuticals Llc | SAFE CHEMICAL UNCOUPLERS FOR TREATING OBESITY |
| FR2849598B1 (en) * | 2003-01-07 | 2006-09-22 | Merck Sante Sas | USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES BY INCREASING THE NUMBER OF CELLS OF THE LANGERHANS ISLANDS |
| FR2849599B1 (en) * | 2003-01-07 | 2006-12-29 | Merck Sante Sas | USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES |
| CN1774244A (en) * | 2003-04-15 | 2006-05-17 | 维尔斯达医疗公司 | Compounds for the treatment of metabolic disorders |
| ES2368692T3 (en) | 2007-12-03 | 2011-11-21 | Merck Patent Gmbh | USE OF 4-OXOBUTANOIC ACID DERIVATIVES IN THE TREATMENT OF ASSOCIATED PATHOLOGIES WITH IMMUNE DISORDERS. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1190340B (en) * | 1986-06-06 | 1988-02-16 | Roussel Maestretti Spa | DERIVATIVES OF 4-FENYL 4-BONE 2-BUTENOIC ACID, THEIR PREPARATION PROCEDURE AND THEIR USE AS MEDICINAL PRODUCTS |
| DK523288A (en) * | 1987-10-06 | 1989-04-07 | Hoffmann La Roche | AMINO ACID DERIVATIVES |
| US5250517A (en) * | 1987-10-06 | 1993-10-05 | Hoffmann-La Roche Inc. | Renin inhibiting compounds |
| CA1329680C (en) * | 1987-11-23 | 1994-05-17 | Harold Norris Weller, Iii | N-heterocyclic alcohol derivatives |
| US5055466A (en) * | 1987-11-23 | 1991-10-08 | E. R. Squibb & Sons, Inc. | N-morpholino derivatives and their use as anti-hypertensive agents |
| FR2733750B1 (en) | 1995-05-03 | 1997-06-13 | Synthelabo | DERIVATIVES OF GAMMA-OXO-ALPHA- (PHENYLMETHYL) -5,6- DIHYDRO-4H-THIENO (3,4-C) PYRROLE-5-BUTANOIQUE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
-
1996
- 1996-08-16 FR FR9610254A patent/FR2752422B1/en not_active Expired - Fee Related
-
1997
- 1997-05-08 UA UA99031301A patent/UA57031C2/en unknown
- 1997-08-05 CN CN97197180A patent/CN1082370C/en not_active Expired - Fee Related
- 1997-08-05 PT PT97936682T patent/PT925273E/en unknown
- 1997-08-05 TR TR1999/00329T patent/TR199900329T2/en unknown
- 1997-08-05 CA CA002263348A patent/CA2263348C/en not_active Expired - Fee Related
- 1997-08-05 HU HU0004223A patent/HUP0004223A3/en unknown
- 1997-08-05 AT AT97936682T patent/ATE208364T1/en not_active IP Right Cessation
- 1997-08-05 RU RU99105208/04A patent/RU2175966C2/en not_active IP Right Cessation
- 1997-08-05 JP JP10510330A patent/JP3105545B2/en not_active Expired - Fee Related
- 1997-08-05 US US09/230,849 patent/US6143787A/en not_active Expired - Fee Related
- 1997-08-05 BR BR9711315A patent/BR9711315A/en not_active IP Right Cessation
- 1997-08-05 WO PCT/EP1997/004252 patent/WO1998007681A1/en not_active Ceased
- 1997-08-05 CZ CZ1999498A patent/CZ294165B6/en not_active IP Right Cessation
- 1997-08-05 KR KR10-1999-7001122A patent/KR100488430B1/en not_active Expired - Fee Related
- 1997-08-05 DK DK97936682T patent/DK0925273T3/en active
- 1997-08-05 SK SK180-99A patent/SK283055B6/en not_active IP Right Cessation
- 1997-08-05 ES ES97936682T patent/ES2166098T3/en not_active Expired - Lifetime
- 1997-08-05 SI SI9730237T patent/SI0925273T1/en unknown
- 1997-08-05 EP EP97936682A patent/EP0925273B1/en not_active Expired - Lifetime
- 1997-08-05 AU AU39422/97A patent/AU725440B2/en not_active Ceased
- 1997-08-05 DE DE69708130T patent/DE69708130T2/en not_active Expired - Lifetime
- 1997-08-14 ZA ZA9707327A patent/ZA977327B/en unknown
- 1997-08-14 ID IDP972848A patent/ID17875A/en unknown
- 1997-08-15 AR ARP970103720A patent/AR009251A1/en active IP Right Grant
- 1997-10-23 TW TW086115700A patent/TW438764B/en active
-
1999
- 1999-02-12 PL PL97331645A patent/PL187371B1/en not_active IP Right Cessation
- 1999-02-15 NO NO19990707A patent/NO312290B1/en not_active IP Right Cessation
-
2002
- 2002-09-24 CY CY0200057A patent/CY2298B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID20807A (en) | SULFONILAMINOKARBOKSILAT ACID | |
| ID20809A (en) | SUBSTITUTED DIAMINOCARBOXICATE ACID | |
| ID24686A (en) | AMINO ACID BIOSINETIC PLANTS | |
| FI20071025L (en) | Pharmaceutical compositions | |
| NO20004345D0 (en) | Pharmaceutical composition | |
| ID18352A (en) | PHARMACEUTICAL COMPOSITIONS | |
| FI991302A7 (en) | Improved pharmaceutical compositions | |
| ID22053A (en) | AMINOFOSFONATE ACID DURATION IN PHARMACEUTICAL PROPERTIES | |
| ID24596A (en) | PHARMACEUTICAL MICROSPHERE WHICH CONTAIN VALPROAT ACID FOR ORAL USAGE | |
| ID18712A (en) | 4-BIFENYL-4-HYDROXYBUTIRATE ACIDED SUBSTANCES AS METALOPROTEASE MATRIERS | |
| ID17875A (en) | PHARMACEUTICAL COMPOSITION THAT CONTAINS 4-OXSOBUTANOIC ACID | |
| EE9800400A (en) | Pharmaceutical compositions containing diclofenac | |
| BR9507768A (en) | Pharmaceutical composition | |
| FI973229A7 (en) | New pharmaceutical composition | |
| LV11727A (en) | Pharmaceutical composition | |
| ID18698A (en) | PHARMACEUTICAL COMPOSITION | |
| ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
| ID27729A (en) | ANTI-ENZYM COMPOSITION THAT CONTAINS ACIDICINATE ACID | |
| ITMI942166A0 (en) | PHARMACEUTICAL COMPOSITIONS MIORELAXANTS | |
| FI973280L (en) | Pharmaceutical composition | |
| ID21355A (en) | MAKING ADIPAT ACID | |
| FI961364L (en) | Drug composition | |
| ID22212A (en) | HYDROXIC ACID PLANTATIONS | |
| ITMI962628A0 (en) | PHARMACEUTICAL COMPOSITION | |
| FI962738A7 (en) | Pharmaceutical compositions |